Dan Wattier

Co-founded, Valocor Therapeutics

Role: Associate

Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin

Stream: Advanced Therapies

Biotechnology commercial leader and entrepreneur. Previously co-founder and CEO of ARNA Therapeutics (aka ImStar), a private biotech company leveraging RNA biology to discover treatments for ALS and neurodegenerative diseases. Also co-founded Valocor Therapeutics and led that company from inception until merging to become Dermira (Nasdaq: DERM). Dermira was acquired in 2020 by Lilly for $1.1B. Over 20 years leadership expertise in the biopharmaceutical industry. Notably, was responsible for the US commercial launch of Remicade, acquired by Johnson & Johnson, which ultimately reached over $10B in annual sales worldwide.